CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Biomarker
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
    Technologies and Software
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Pharma Wholesale and Distribution Latam

Top Pharmaceutical Drug Import Solutions in Latin America 2026

Pharmaceutical drug import solutions help healthcare suppliers manage the international sourcing and distribution of medicinal products. With a focus on import compliance, product documentation, supply coordination and quality assurance, they support reliable pharmaceutical availability and safer cross-border distribution.

Solutions
Medssey: A Structured Route to Reliable Medicine Access
Medssey
A Structured Route to Reliable Medicine Access
Mariana de Souza Gomes, Founder and CEO
Medssey structures international medicine imports around a simple premise: the legal route must be defined before the shipment moves. Many needed medicines are unregistered in Brazil, in shortage or available only in presentations approved abroad. For clinics, hospitals, public health bodies and patients, the first challenge is often not sourcing or transport, but determining who may lawfully import, which Anvisa framework applies and who can pay the overseas supplier.
Read more
State of Industry

Pharmaceutical Distribution Infrastructure: Building Resilient Latin American Networks

Pharmaceutical drug import solutions in Latin America are becoming increasingly important as healthcare systems expand access to medicines while navigating complex regional supply chains, regulatory structures, and distribution demands. Many countries across the region rely on imported pharmaceuticals to support hospitals, pharmacies, specialty treatment centers, and public healthcare programs, particularly for advanced therapies, biologics, vaccines, and critical medications that may not be manufactured domestically at sufficient scale.

Read more
Deep Dive

Pharmaceutical Import Providers Must Establish the Legal Route

A hospital may locate a prescribed medicine abroad yet remain unable to purchase it. In Brazil, drugs lacking local registration or facing shortages can require different import arrangements depending on who is legally authorized to import and who will pay. Patient-directed orders and institutional procurement follow distinct rules. An incorrectly structured transaction can stall before customs clearance, regardless of supplier readiness. Before accepting a proposed delivery date, executives need to know whether a provider can establish a lawful import and payment structure.

Read more
Leadership Perspective
A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and Innovations
Shionogi
A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and Innovations
Safwan Kezbor, M.D, Global Medical Lead (Senior Medical Director), Clinical Development

Rare disease conditions are defined as any disease that affects less than 200,000 people in the U.S. According to the National Institutes of Health (NIH), there are around 7,000 rare diseases impacting more than 30 million people in the U.S. Nevertheless, only about 10% of these diseases have approved treatments. Many treatment options are still symptomatic and supportive therapy for a large number of these diseases. This presents a huge unmet medical need for a significant number of patients and families dealing with these conditions. Although they are considered rare, these diseases can have a significant impact on patients and their families, disrupting their life and often leading to disability and premature death.

Read more

Pharmaceutical Drug Import Solutions in Latin America Info

Q1
What Do Pharmaceutical Drug Import Solutions Cover?
Pharmaceutical drug import solutions manage the steps involved in bringing medicines across national borders for patients and healthcare institutions. The work can include identifying an appropriate overseas supplier, checking whether a medicine can be imported, preparing regulatory and customs documents, arranging international payment and coordinating delivery. Top Pharmaceutical Drug Import Solutions bring these connected tasks into a planned process, helping prevent gaps between sourcing, regulatory approval and final receipt.
Q2
Why Are Pharmaceutical Drug Import Solutions Important for Medicine Access?
Access to certain treatments can depend on imports when a medicine is not registered locally, is in short supply or is available only in a formulation approved in another country. Top Pharmaceutical Drug Import Solutions help patients, hospitals and public health bodies navigate these situations. Demand is shaped by treatment needs, supply shortages and differences in medicine availability between countries. A clear import route can reduce avoidable delays and help maintain continuity of care.
Q3
Which Provider Did Life Sciences Review Recognize for Pharmaceutical Drug Import Solutions in 2026?
Life Sciences Review recognized Medssey as a provider of Top Pharmaceutical Drug Import Solutions in Latin America in 2026. The recognition places attention on the role of structured medicine imports in improving access across borders. Such operations require more than finding a product abroad; they must also address the legal, regulatory, financial and logistical steps that allow a medicine to reach its intended recipient.
Q4
What Should Patients and Healthcare Institutions Evaluate Before Arranging a Medicine Import?
A sound import process should begin by confirming the prescription, medicine details and applicable import rules. Patients and institutions should understand who is legally permitted to import, which documents are required, how overseas payment will be handled and who is responsible for customs clearance. Top Pharmaceutical Drug Import Solutions should also make costs, delivery expectations and shipment status clear. For temperature-sensitive medicines, storage and transport controls are essential to protect product quality.
Q5
How Do Regulatory Expertise and Logistics Shape Pharmaceutical Drug Imports?
Importing medicines calls for coordination between regulatory knowledge and practical logistics. Requirements may differ for personal-use and institutional imports, while customs procedures, foreign-exchange rules and product-specific storage conditions can affect each shipment. Top Pharmaceutical Drug Import Solutions rely on accurate documentation, suitable transport, temperature monitoring where needed and clear responsibility at each stage. These controls help limit shipment holds, protect medicine quality and give patients and institutions greater visibility.
Q6
What Led to Medssey’s Recognition in the Pharmaceutical Drug Import Category?
Medssey’s work combines regulatory planning with end-to-end import coordination. It checks the medicine and treatment details before arranging an import route, coordinates sourcing and Anvisa filings, and manages customs, payment and delivery through one point of accountability. For cold-chain shipments, it plans qualified packaging and uses data loggers to monitor conditions. It also maintains a dossier of key records and provides clients with updates across defined stages.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review . All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/a/pharmaceutical-drug-import-solutions-in-latin-america